Visedge
Oral antineoplastic, Hedgehog pathway inhibitor indicated for the treatment of adult patients with metastatic and/or locally advanced basal cell carcinoma.
Therapeutic Area
Antineoplastic
Active Ingredient
Vismodegib
Line
Oncology
Dosage form
Hard capsules of 150mg x 28 caps
